Pharmaceutical companies marketing products in Europe could be set for a commercial boost, after legislators have agreed on a new regulatory framework in a bid to increase competitiveness. The European Parliament (EP) and EU Council negotiators reached a provisional agreement that proposes the introduction of a regulatory protection period and the granting of market protection for certain new medications. The deal, which was reached after a negotiation between co-legislators, is expected to be formally ...